by Clinical Neuropsychologist Online | Friday, September 4, 2026 | Dementia
Dementia, Ahead of Print. Dementia is an umbrella term for progressive conditions affecting memory, thinking, communication and other cognitive functions. These changes can make social interaction challenging, particularly in unfamiliar or overstimulating...
by Clinical Neuropsychologist Online | Friday, September 4, 2026 | Dementia
Abstract Early disruption of gamma oscillations is increasingly recognized as a contributor to neurodegeneration and cognitive decline in Alzheimer’s disease (AD), positioning 40-Hz stimulation as a promising neuromodulatory strategy. However, its...
by Clinical Neuropsychologist Online | Thursday, September 3, 2026 | Dementia
Dementia, Ahead of Print. Stigmatizing accounts of dementia emphasize tragedy, constructing people living with dementia as ‘unagentic’ and ‘failed’ aging subjects, and cognitive changes as a loss of self. This stigma has significant consequences for people living with...
by Clinical Neuropsychologist Online | Wednesday, September 2, 2026 | Dementia
Alzheimer’s &Dementia, Volume 22, Issue 9, September 2026. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | September 2, 2026 Neuro-Dementia...
by Clinical Neuropsychologist Online | Wednesday, September 2, 2026 | Dementia
Alzheimer’s &Dementia, Volume 22, Issue 9, September 2026. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | September 2, 2026 Neuro-Dementia...
by Clinical Neuropsychologist Online | Tuesday, September 1, 2026 | Dementia
Abstract INTRODUCTION Plasma phosphorylated tau (p-tau), particularly p-tau217, is a highly specific biomarker of Alzheimer’s disease (AD) pathology. However, plasma p-tau217 can be elevated in rare non-AD conditions. Brain-derived (BD) p-tau217 may reduce these...